S. ÖZAKBAŞ Et Al. , "Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial," CLINICAL NEUROLOGY AND NEUROSURGERY , vol.160, pp.69-72, 2017
ÖZAKBAŞ, S. Et Al. 2017. Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial. CLINICAL NEUROLOGY AND NEUROSURGERY , vol.160 , 69-72.
ÖZAKBAŞ, S., Cinar, B. P., Kosehasanogullari, G., Kahraman, T., Oz, D., & Kursun, B. B., (2017). Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial. CLINICAL NEUROLOGY AND NEUROSURGERY , vol.160, 69-72.
ÖZAKBAŞ, SERKAN Et Al. "Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial," CLINICAL NEUROLOGY AND NEUROSURGERY , vol.160, 69-72, 2017
ÖZAKBAŞ, SERKAN Et Al. "Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial." CLINICAL NEUROLOGY AND NEUROSURGERY , vol.160, pp.69-72, 2017
ÖZAKBAŞ, S. Et Al. (2017) . "Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial." CLINICAL NEUROLOGY AND NEUROSURGERY , vol.160, pp.69-72.
@article{article, author={SERKAN ÖZAKBAŞ Et Al. }, title={Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial}, journal={CLINICAL NEUROLOGY AND NEUROSURGERY}, year=2017, pages={69-72} }